Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|February 12, 2022
Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessmentYuan Li, Xiangyi Kong, Zhongzhao Wang, et al.European Journal of Medical Research|July 26, 2024
Baicalin promotes the sensitivity of NSCLC to cisplatin by regulating ferritinophagy and macrophage immunity through the KEAP1-NRF2/HO-1 pathwayYang Chen, Shujun Bao, Zhongzhao Wang, et al.The Clinical Respiratory Journal|March 7, 2026
Small Airway Function as an Indicator for Persistent Airflow Limitation Asthma: A Retrospective StudyZhongzhao Wang, Xintong Du, Yang Luo, et al.Discover Oncology|November 10, 2024
A novel double fusion of EML4-ALK and PLEKHA7-ALK contribute to rapid progression of lung adenocarcinoma: a case report and literature reviewZhongzhao Wang, Yang Luo, Heng Gong, et al.Journal of Cellular and Molecular Medicine|October 15, 2021
Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatmentYuan Li, Xiangyi Kong, Lixue Xuan, et al.Frontiers in Pharmacology|May 6, 2022
PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential MechanismHao Dong, Yihang Qi, Xiangyi Kong, et al.Frontiers in Microbiology|December 20, 2018
Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut MicrobiotaJialin Liu, Ruirui Chang, Xiaobei Zhang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 1, 2002
Expression of extracellular signal-regulated kinase and its relationship with clinicopathological characteristics of breast cancerZhongzhao Wang, Shan Wang, Fengxue Zhu, et al.Cancer Management and Research|March 19, 2020
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic IndicatorLi Chen, Xiangyi Kong, Zhongzhao Wang, et al.Frontiers in Pharmacology|April 4, 2022
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune DiseasesKe Zhang, Xiangyi Kong, Yuan Li, et al.Pageof 6